To assist eye care professionals in attracting and retaining new contact lens wearers, CooperVision has introduced a suite of practice support tools for its clariti® 1 day family of silicone hydrogel lenses. The toolkit provides resources for engaging prospective contact lens wearers before their scheduled exam, during their time in the office, and throughout their first few months of wear.
Contact lens dropout continues to be a challenge for eye care professionals, resulting in a significant loss of revenue each year.1 However, dropout can be reduced with support for new wearers in the critical first few months. In a survey, after three and six months of starting contact lens wear, 31% of respondents noted they would likely stop using contact lenses in the next six months.2
“When it comes to meeting the needs of new contact lens wearers, clariti® 1 day provides ‘ease at first sight’,” said Michele Andrews, OD, Vice President, Professional & Government Affairs, Americas, CooperVision. “This lens helps practitioners overcome any of the typical barriers when fitting a new wearer; clariti® 1 day is affordable3, sustainable, easy to fit4, and provides all of the ocular health benefits of a silicone hydrogel lens*. And with these new practice tools, doctors and staff now have even more support to help ensure patient success.”
CooperVision’s clariti® 1 day new wearer toolkit features a streamlined consumer tips website that helps first-time contact lens wearers easily adapt to the routine with step-by-step instructions and an interactive video tutorial for inserting and removing lenses. The site also includes informational articles on topics such as how to use makeup or eye drops with contact lenses, and how to travel with contact lenses.
“In the first few weeks with contact lenses, new wearers often have a lot of questions. With access to this digital resource designed specifically for them, practices can provide much-needed assistance—whenever and wherever the patient may need it,” said Dr. Andrews.
The toolkit also includes a variety of resources to facilitate pre-visit patient engagement, as well as eco-friendly in-office training tools. Many of the materials feature QR codes that link wearers directly to the consumer tips website. These practice resources can be downloaded at https://coopervision.com/practitioner/build-your-practice/marketing-support/marketing-materials/clariti-1-day.
Last year, CooperVision made clariti® 1 day the first net plastic neutral contact lens5 through a groundbreaking partnership with Plastic Bank®. For every box of clariti® 1 day distributed in the United States since the start of 2021, CooperVision purchases credits from Plastic Bank® for the collection, processing, and reuse of general plastic waste that is equal to the weight of the plastic contained in clariti® 1 day lenses and packaging.6
The full family of clariti® 1 day lenses—sphere, toric, and multifocal—enable eye care professionals to fit more of their patients in silicone hydrogel 1-day lenses,7 including new wearers. clariti® 1 day lenses feature a high oxygen transmissibility (up to 3x the Dk/t of some hydrogel 1-day toric lenses8), allowing for 100 percent corneal oxygen consumption9 which helps maintain ocular health. 96% of eye care professionals agree that a contact lens with high levels of oxygen transmissibility makes them feel confident in fitting clariti 1 day for a patient new to contact lenses.10 In addition, the lenses’ high water content supports excellent all-day comfort.11 CooperVision is also able to offer clariti® 1 day at a price comparable to daily disposable hydrogel contact lenses.12 In fact, 4 out of 5 eye care professionals agree that clariti® 1 day offers new wearers excellent value for the money.13
With higher oxygen delivery than hydrogel materials, SiHy materials minimize or eliminate hypoxia-related complications during daily wear.
Nguyen, T L. How to Reduce Contact Lens Dropouts. Review of Optometric Business, 28 June 2017.
2 YouGov Plc. Total sample size was 1013 adults (511 US adults and 502 German adults). Fieldwork was undertaken between October 24th and November 9th, 2018. The survey was carried out online.
3 CVI data on file 2022. Verve Online Survey with US ECPs who fit clariti® 1 day or private label version. n=121 (79% strongly agree/agree).
4 Observational satisfaction survey involving 1718 patients (new lens wearers n=1091, refitted lens wearers n=627) who were fitted with clariti® 1 day.
5 CVI data on file 2020. Sustainability report, clariti® 1 day in U.S. Based on top 4 global contact lens manufacturers. clariti® 1 day is defined as orders and includes clariti® 1 day sphere, clariti® 1 day toric, and clariti® 1 day multifocal product sold & distributed by CooperVision in the US. 2. Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways.. CooperVision purchases credits equal to the weight of plastic in clariti® 1 day orders in a specified time period. clariti® 1 day plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).
6 Amount is defined as weight. Net plastic neutrality is established by purchasing credits from Plastic Bank. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in clariti® 1 day orders in a specified time period. clariti® 1 day plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).
7 CVI data on file 2021; Rx coverage database n=203,946 eyes; 14 to 41 years for clariti® 1 day sphere and clariti® 1 day toric; 42 to 70 years for clariti® 1 day multifocal. Combined 82.2% coverage.
8 Based on manufacturers published data. clariti 1 day has Dk/t of 86. Compared to Proclear 1 day (Dk/t 28), 1-day Acuvue Moist (Dk/t 25.5), Dailies Aquacomfort Plus (Dk/t 26) and Biotrue ONEday (Dk/t 42).
9 Brennan NA. Beyond Flux: Total Corneal Oxygen Consumption as an Index of Corneal Oxygenation During Contact Lens Wear. Optom Vis Sci. 2005;82(6):467-472.
10 CVI data on file 2022. Verve Online Survey with US ECPs. n=192..
11 CooperVision data on file, 2019. clariti® 1 day Wearer Experience Survey conducted online in U.S., n=298: sphere, toric or multifocal; habitual FRP, DD, and new wearers who purchased clariti® 1 day; strongly or somewhat agree.
12 Based on 166 participating eye care professionals in a multi-national online survey, 2016.
13 CVI data on file 2022. Verve Online Survey with US ECPs who fit clariti® 1 day or private label version. n=121 (79% strongly agree/agree).
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.